Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Depomed, Inc. (DEPO)

« Back to company index

DEPO Chatter Timeline

Stock Ticker for DEPO

Most Active Tweeters for DEPO

UserTweets
@StockTexts 1

Recent Tweets for DEPO

StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 4 https://t.co/X0jXTcompF
June 14th 2019, 5:06pm
DataTrials @DataTrials
$DEPO Phase 2 Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea… Estimated Primary Completion Date - 06/2019
May 13th 2019, 4:05pm
CSIMarket @CSIMarket
$DEPO #stock #StockMarket #AssertioTherapeutics publishes on https://t.co/savSNU1XbB DEPO reported disastrous Q1,… https://t.co/Pbw057cBXX
May 12th 2019, 12:05pm
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form S-8 https://t.co/BTWBZZdHBV
May 10th 2019, 1:05pm
Allstocknews @Allstocknews
$DEPO New Form S-8 for Assertio Therapeutics, Inc. From our Stock News Alerts App
May 10th 2019, 1:05pm
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 4 https://t.co/rtLH1IUuNz
May 9th 2019, 11:05am
Allstocknews @Allstocknews
$DEPO New Form 10-Q for Assertio Therapeutics, Inc. From our Stock News Alerts App
May 9th 2019, 9:05am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 10-Q https://t.co/WKWLfvg8d0
May 9th 2019, 9:05am
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics Announces First-Quarter 2019 Financial Results From our Stock News Alerts App
May 8th 2019, 4:05pm
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form 8-K (No. 0001005201-19-000060): https://t.co/BSQIN3FeWd
May 8th 2019, 8:05am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 8-K https://t.co/I804MwFEZK
May 8th 2019, 7:05am
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics to Report First Quarter 2019 Financial Results After The Close of Markets on Wedn From our Stock News Alerts App
April 24th 2019, 4:04pm
bbnsnews @bbnsnews
Head to Head Survey: Aduro BioTech $ADRO and Depomed $DEPO https://t.co/KYVIK0yoXy
April 17th 2019, 7:04am
happyycamperr @happyycamperr
@Ethyl_Eico similar to what $DEPO did with Glumetza for years
April 16th 2019, 1:04pm
WeekHerald @WeekHerald
Depomed $DEPO versus Aduro BioTech $ADRO Head to Head Survey https://t.co/leWN5mPQC4
April 15th 2019, 5:04am
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form DEF 14A (No. 0001047469-19-002034): https://t.co/nM4qQz9rNE
April 8th 2019, 6:04am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form DEF 14A https://t.co/sjNGgRxYDI
April 8th 2019, 6:04am
Allstocknews @Allstocknews
$DEPO New Form DEF 14A for Assertio Therapeutics, Inc. From our Stock News Alerts App
April 8th 2019, 6:04am
ExecPayOrg @ExecPayOrg
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M https://t.co/eOoN8CmxQp $DEPO #execpay
April 8th 2019, 6:04am
confcalltran @confcalltran
Depomed releases salary data. CEO sees compensation rise 0%25 https://t.co/WVSm7YiONh $DEPO
April 8th 2019, 6:04am
confcalltran @confcalltran
Depomed director was just granted 37,475 restricted shares https://t.co/ihVbsXuiaT $DEPO
April 2nd 2019, 9:04am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 3 https://t.co/aiDVJMqfeo
April 2nd 2019, 9:04am
confcalltran @confcalltran
Depomed director just declared 0 ownership of the company. https://t.co/sLd4wgPGEI $DEPO
April 2nd 2019, 9:04am
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form 8-K (No. 0001005201-19-000050): https://t.co/ut2hgVDHkB
April 1st 2019, 9:04am
confcalltran @confcalltran
Departure of Directors or Certain https://t.co/HWGHL8Qew9 $DEPO
April 1st 2019, 9:04am
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 8-K https://t.co/BXFHM2dsxS
April 1st 2019, 9:04am
Allstocknews @Allstocknews
$DEPO New Form 8-K for Assertio Therapeutics, Inc. From our Stock News Alerts App
April 1st 2019, 9:04am
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics Announces Appointment of Jay Galeota to Board of Directors From our Stock News Alerts App
April 1st 2019, 9:04am
Stock_News_Now @Stock_News_Now
$DEPO: New SEC Filing for DEPO: Form 8-K (No. 0001104659-19-018237): https://t.co/u4Qwx9YSFJ
March 28th 2019, 4:03pm
Allstocknews @Allstocknews
$DEPO Assertio Therapeutics Announces Favorable NUCYNTA® Patent Ruling From our Stock News Alerts App
March 28th 2019, 2:03pm
StockTexts @StockTexts
$DEPO Depomed, Inc. SEC Filing: Form 4 https://t.co/VaRc1GcPSK
March 18th 2019, 8:03am
Allstocknews @Allstocknews
$DEPO New Form 4 for Assertio Therapeutics, Inc. From our Stock News Alerts App
March 18th 2019, 8:03am
confcalltran @confcalltran
Director of Depomed just picked up 10,000 shares https://t.co/bQVy48dvhp $DEPO
March 18th 2019, 8:03am
confcalltran @confcalltran
SVP of Depomed just picked up 5,000 shares https://t.co/vQnOhm8aqf $DEPO
March 18th 2019, 8:03am
confcalltran @confcalltran
Depomed's SVP and CFO just picked up 6,000 shares https://t.co/qOa0ANznpr $DEPO
March 18th 2019, 8:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.